急性冠脉综合征患者经18F-DPA-714 PET/CT测得的造血与髓系细胞反应持续存在
本研究在8例急性冠脉综合征(ACS)患者和8例匹配健康对照中,于急性期及ACS后3个月行18F-DPA-714 PET/CT,并在20例患者和19例对照中行流式细胞术。急性期患者骨髓和脾脏摄取分别较对照高1.4倍和1.3倍,循环造血干/祖细胞高2.4倍;3个月后骨髓摄取显著下降,但脾脏摄取和循环造血干/祖细胞未下降。
要点
- ACS急性期骨髓18F-DPA-714摄取较健康对照高1.4倍(p=0.012),脾脏高1.3倍(p=0.039)。
- ACS急性期循环造血干/祖细胞数量较健康对照高2.4倍(p=0.001)。
- ACS后3个月骨髓摄取较急性期显著下降(p=0.002),但脾脏摄取(p=0.67)和循环造血干/祖细胞(p=0.75)未下降。
核心结论
- 18F-DPA-714 PET/CT显示ACS触发造血器官激活,作为持续超过3个月的细胞炎症反应的启动因素,其特征是循环白细胞及其前体数量增多。
研究设计与样本
- 在8例ACS患者和8例匹配健康对照中,于急性期及ACS后3个月行18F-DPA-714 PET/CT。
- 在20例ACS患者急性期及ACS后3个月和19例健康对照中,用流式细胞术检测循环单核细胞和造血干/祖细胞(HSPCs)。
主要发现
- 急性期患者骨髓18F-DPA-714摄取较健康对照高1.4倍(p=0.012),脾脏摄取较健康对照高1.3倍(p=0.039)。
- 急性期患者循环HSPCs数量较健康对照高2.4倍(p=0.001)。
- ACS后3个月骨髓18F-DPA-714摄取较急性期显著下降(p=0.002),但脾脏摄取(p=0.67)和循环HSPCs数量(p=0.75)未下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: An acute coronary syndrome (ACS) is characterized by a multi-level inflammatory response, comprising activation of bone marrow and spleen accompanied by augmented release of leukocytes into the circulation. The duration of this response after an ACS remains unclear. Here, we assessed the effect of an ACS on the multi-level inflammatory response in patients both acutely and after 3 months. METHODS: We performed 18F-DPA-714 PET/CT acutely and 3 months post-ACS in eight patients and eight matched healthy controls. DPA-714, a PET tracer binding the TSPO receptor and highly expressed in myeloid cells, was used to assess hematopoietic activity. We also characterized circulating monocytes and hematopoietic stem and progenitor cells (HSPCs) by flow cytometry in 20 patients acutely and 3 months post-ACS and in 19 healthy controls. RESULTS: In the acute phase, patients displayed a 1.4-fold and 1.3-fold higher 18F-DPA-714 uptake in, respectively, bone marrow (p = 0.012) and spleen (p = 0.039) compared with healthy controls. This coincided with a 2.4-fold higher number of circulating HSPCs (p = 0.001). Three months post-ACS, 18F-DPA-714 uptake in bone marrow decreased significantly (p = 0.002), but no decrease was observed for 18F-DPA-714 uptake in the spleen (p = 0.67) nor for the number of circulating HSPCs (p = 0.75). CONCLUSIONS: 18F-DPA-714 PET/CT reveals an ACS- triggered hematopoietic organ activation as initiator of a prolonged cellular inflammatory response beyond 3 months, characterized by a higher number of circulating leukocytes and their precursors. This multi-level inflammatory response may provide an attractive target for novel treatment options aimed at reducing the high recurrence rate post-ACS.
引用
- Verweij SL, Stiekema LCA, Delewi R, et al. Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT. Eur J Nucl Med Mol Imaging. 2018. PMID: 29728748. doi:10.1007/s00259-018-4038-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。